Exelby P R, Filler R M, Grosfeld J L
J Pediatr Surg. 1975 Jun;10(3):329-37. doi: 10.1016/0022-3468(75)90095-0.
A review of 227 cases of hepatoblastoma, hepatic cell carcinoma in children seen in the United States over a 10-yr period is presented. Both tumors were seen most commonly in infancy, but the hepatocellular carcinoma shows a second peak of incidence around puberty. Males predominated in both diseases more so in hepatoblastoma. Presenting symptoms in both diseases were very similar, most commonly an upper abdominal mass or abdominal enlargement associated with anorexia and weight loss. In the preoperative evaluation the presence of alpha-feto protein was one of the most helpful diagnostic tests. Disturbances of liver function were usually mild but were more marked in those children with hepatocellular carcinoma. Preoperative x-rays were abnormal in a large percentage of cases with the hepatic arteriogram and vena cavagram being the most useful diagnostic x-rays for liver tumors. Liver scans were positive for liver tumor in 95% of the children when this test was carried out. The follow-up for these patients ranged from 2 to 10 yr. The size of the primary tumor did not appear to correlate with survival but bilateral location of the tumor, 33% in hepatoblastoma and 45% in hepatocellular carcinoma, made many of these tumors inoperable. Multicentric tumors were also found in a large number of patients, being more common in hepatocellular carcinoma. There was a high rate of local recurrence or local extension after operation in both diseases, and metastatic spread was similar being most common to the lungs and abdomen. A wide variety of surgical procedures were carried out in these patients from biopsy only to extended hepatic lobectomy. When incomplete excision or biopsy only was carried out no patient survived in either group. Among the hepatoblastoma patients, 45 of 78 patients who had complete excision are surviving. In the hepatocellular carcinoma patients where the operability rate was much lower 12 of 33 patients are surviving when tumor was completely excised. Complications were frequent, the most common being excessive blood loss at operation. There were eight operative deaths and 17 postoperative deaths in the combined group. There was no evidence that radiation therapy or chemotherapy controlled disease which could not be completely excised surgically. The only direct evidence of a favorable effect of radiation and chemotherapy were three cases of hepatoblastoma in which the tumor changed from inoperable to operable by a combination of radiation therapy and multiple drug chemotherapy. Both tumors are highly malignant, and 90% of the children who died of hepatoblastoma died within 12 mo of diagnosis. In the hepatocellular carcinoma 80% of the deaths occurred within 1 yr of diagnosis. At this time it seems that operative excision offers the only chance of cure in children with these tumors and cure rates of 60% can be expected with hepatoblastoma and 33% in hepatocellular carcinoma if the tumor can be completely excised.
本文对美国10年间诊治的227例儿童肝母细胞瘤和肝细胞癌进行了回顾。这两种肿瘤在婴儿期最为常见,但肝细胞癌在青春期前后出现第二个发病高峰。两种疾病中男性均占主导,肝母细胞瘤中更为明显。两种疾病的首发症状非常相似,最常见的是上腹部肿块或腹部增大,伴有厌食和体重减轻。在术前评估中,甲胎蛋白的存在是最有用的诊断测试之一。肝功能障碍通常较轻,但在肝细胞癌患儿中更为明显。术前X线检查在大多数病例中异常,肝动脉造影和腔静脉造影是肝脏肿瘤最有用的诊断性X线检查。当进行此项检查时,95%的患儿肝脏扫描显示肝脏肿瘤阳性。这些患者的随访时间为2至10年。原发肿瘤的大小似乎与生存率无关,但肿瘤的双侧位置,肝母细胞瘤中占33%,肝细胞癌中占45%,导致许多此类肿瘤无法手术切除。在大量患者中也发现了多中心肿瘤,在肝细胞癌中更为常见。两种疾病术后局部复发或局部扩展的发生率都很高,转移扩散情况相似,最常见于肺和腹部。这些患者接受了多种手术,从仅活检到扩大肝叶切除术。如果仅进行不完全切除或活检,两组患者均无存活。在肝母细胞瘤患者中,78例接受完全切除的患者中有45例存活。在肝细胞癌患者中,手术切除率低得多,33例肿瘤完全切除的患者中有12例存活。并发症很常见,最常见的是手术中失血过多。联合组有8例手术死亡和17例术后死亡。没有证据表明放疗或化疗能控制无法手术完全切除的疾病。放疗和化疗产生有利效果的唯一直接证据是3例肝母细胞瘤,通过放疗和多种药物化疗联合,肿瘤从无法手术变为可手术。这两种肿瘤都是高度恶性的,90%死于肝母细胞瘤的儿童在诊断后12个月内死亡。在肝细胞癌中,80%的死亡发生在诊断后1年内。目前看来,手术切除是这些肿瘤患儿唯一的治愈机会,如果肿瘤能完全切除,肝母细胞瘤的治愈率可达60%,肝细胞癌可达33%。